SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-24-043099
Filing Date
2024-04-03
Accepted
2024-04-03 16:06:40
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 tm2410156-1_s3.htm S-3 393525
2 EXHIBIT 5.1 tm2410156d2_ex5-1.htm EX-5.1 9632
3 EXHIBIT 23.2 tm2410156d2_ex23-2.htm EX-23.2 2283
4 EXHIBIT 23.3 tm2410156d2_ex23-3.htm EX-23.3 2778
5 EX-FILING FEES tm2410156d2_ex-filingfees.htm EX-FILING FEES 19039
6 GRAPHIC lg_apreatherapeutics-4c.jpg GRAPHIC 27485
  Complete submission text file 0001104659-24-043099.txt   465336
Mailing Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902
Business Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902 617-463-9385
Aprea Therapeutics, Inc. (Filer) CIK: 0001781983 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-278485 | Film No.: 24818723
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)